Clinical Trial Update: Study on Allopregnanolone and Depression in Perimenopausal Women [Phase 4]

View source ↗

Summary

This update reports on a Phase 4 trial evaluating allopregnanolone for depression in perimenopausal women. The study was terminated and results have been posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Brexanolone (allopregnanolone)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Depression | Phase 4 | Status: TERMINATED | Results posted: 2026-01-22